FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alistair Cochran

Research Profile

Disorders

Chemicals & Drugs

Procedures

Anatomy

Co-author Network

Publications

TOP 3
Charles M Balch; jeffrey gershenwald; Seng-Jaw Soong; John F Thompson; Shouluan Ding; David R Byrd; Natale Cascinelli; Alistair Cochran; Daniel G Coit; Alexander M Eggermont; Timothy M Johnson; John M Kirkwood; Stanley P Leong; Kelly M McMasters; Martin C Mihm; Donald L Morton; Merrick I Ross; Vernon K Sondak
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.
Charles M Balch; jeffrey gershenwald; Seng-Jaw Soong; John F Thompson; Michael B Atkins; David R Byrd; Antonio C Buzaid; Alistair Cochran; Daniel G Coit; Shouluan Ding; Alexander M Eggermont; Keith T Flaherty; Phyllis A Gimotty; John M Kirkwood; Kelly M McMasters; Martin C Mihm; Donald L Morton; Merrick I Ross; Arthur J Sober; Vernon K Sondak
Final version of 2009 AJCC melanoma staging and classification.
Rajmohan Murali; Alistair Cochran; Martin G Cook; Joseph D Hillman; Rooshdiya Z Karim; Marc Moncrieff; Hans Starz; John F Thompson; Richard A Scolyer
Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alistair Cochran (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Charles M Balch; jeffrey gershenwald; Seng-Jaw Soong; John F Thompson; Shouluan Ding; David R Byrd; Natale Cascinelli; Alistair Cochran; Daniel G Coit; Alexander M Eggermont; Timothy M Johnson; John M Kirkwood; Stanley P Leong; Kelly M McMasters; Martin C Mihm; Donald L Morton; Merrick I Ross; Vernon K Sondak
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(14):2452-9.
2009: Charles M Balch; jeffrey gershenwald; Seng-Jaw Soong; John F Thompson; Michael B Atkins; David R Byrd; Antonio C Buzaid; Alistair Cochran; Daniel G Coit; Shouluan Ding; Alexander M Eggermont; Keith T Flaherty; Phyllis A Gimotty; John M Kirkwood; Kelly M McMasters; Martin C Mihm; Donald L Morton; Merrick I Ross; Arthur J Sober; Vernon K Sondak
Final version of 2009 AJCC melanoma staging and classification.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(36):6199-206.
2009: Rajmohan Murali; Alistair Cochran; Martin G Cook; Joseph D Hillman; Rooshdiya Z Karim; Marc Moncrieff; Hans Starz; John F Thompson; Richard A Scolyer
Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma.
Cancer 2009;115(21):5026-37.
2009: Annette Hougaard Chakera; Birger Hesse; Zeynep Burak; James R Ballinger; Allan Britten; Corrado Caracò; Alistair Cochran; Martin G Cook; KT Drzewiecki; Richard Essner; Einat Even-Sapir; Alexander M M Eggermont; Tanja Gmeiner Stopar; Christian Ingvar; Martin C Mihm; Stanley W McCarthy; Nicola Mozzillo; Omgo E Nieweg; Richard A Scolyer; Hans Starz; John F Thompson; Giuseppe Trifirò; Giuseppe Viale; Sergi Vidal-Sicart; Roger Uren; Wendy Waddington; Arturo Chiti; Alain Spatz; Alessandro Testori
EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.
European journal of nuclear medicine and molecular imaging 2009;36(10):1713-42.
2008: Donald L Morton; Alistair Cochran; John F Thompson
The rationale for sentinel-node biopsy in primary melanoma.
Nature clinical practice. Oncology 2008;5(9):510-1.
2008: Alistair Cochran; John F Thompson
Lymphatic mapping and sentinel node biopsy: the data unclouded by speculation.
Archives of dermatology 2008;144(5):687-8; author reply 688-9.
2007: Donald L Morton; Alistair Cochran; John F Thompson
Authors' response to a letter to the editor re: Sentinel node biopsy for early-stage melanoma.
Annals of surgery 2007;245(5):828-9.
2007: R A Scolyer; R Murali; jeffrey gershenwald; Alistair Cochran; J F Thompson
Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tell.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):806-8.
2006: Alistair Cochran; Donald L Morton
Detection of clinically relevant melanoma metastases requires focused, not exhaustive, evaluation of sentinel lymph nodes.
The American journal of surgical pathology 2006;30(3):419-20; author reply 420-1.
2005: Richard A Scolyer; John F Thompson; Stanley W McCarthy; jeffrey gershenwald; Merrick I Ross; Alistair Cochran
Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients.
Journal of the American College of Surgeons 2005;201(5):821-3; author reply 823-4.
2005: Jonathan H Lee; Hitoe Torisu-Itakara; Alistair Cochran; Alan Kadison; Young Huynh; Donald L Morton; Richard Essner
Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):107-12.
2004: D L Morton; Alistair Cochran
The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma.
The British journal of dermatology 2004;151(2):308-19.
2004: Ignazio Stanganelli; Alessandro Testori; Maria A Pizzichetta; Alistair Cochran
Dermatoscopic and histopathological diagnosis of primary and metastatic melanoma: report of a workshop at the Third Research Meeting on Melanoma, Milan, Italy, May 2003.
Melanoma research 2004;14(3):231-5.
2003: Eberhard Paul; Irmgard Müller; Helmut Renner; Rolf-Hasso Bödeker; Alistair Cochran
Treatment of locoregional metastases of malignant melanomas with radiotherapy and intralesional beta-interferon injection.
Melanoma research 2003;13(6):611-7.
2003: Paolo A Ascierto; Giuseppe Palmieri; Gerardo Botti; Rocco A Satriano; Ignazio Stanganelli; Riccardo Bono; Alessandro Testori; Leonardo Bosco; Antonio Daponte; Corrado Caracò; Maria Grazia Chiofalo; Maria Teresa Melucci; Rosario Calignano; fabiana tatangelo; Alistair Cochran; Giuseppe Castello
Early diagnosis of malignant melanoma: Proposal of a working formulation for the management of cutaneous pigmented lesions from the Melanoma Cooperative Group.
International journal of oncology 2003;22(6):1209-15.
2003: Alistair Cochran; Christiane Bailly; Eberhard Paul
Optimal surgery for cutaneous melanoma requires accurate and complete pathologic information.
Facial plastic surgery clinics of North America 2003;11(1):23-32.
2001: Ana Maria A Lana; Duan-Ren Wen; Alistair Cochran
The morphology, immunophenotype and distribution of paracortical dendritic leucocytes in lymph nodes regional to cutaneous melanoma.
Melanoma research 2001;11(4):401-10.
2001: Alistair Cochran
The role of practising pathologists in the generation of novel and original observations.
The Journal of pathology 2001;193(1):1-2.
2000: Alistair Cochran; Sunita Bhuta; E Paul; A Ribas
The shifting patterns of metastatic melanoma.
Clinics in laboratory medicine 2000;20(4):759-83, vii.
2000: Alistair Cochran
Melanoma metastases through the lymphatic system.
The Surgical clinics of North America 2000;80(6):1683-93.
2000: Nicolas Bechetoille; Marek Haftek; Marie-Jeanne Staquet; Alistair Cochran; Daniel Schmitt; Odile Berthier-Vergnes
Penetration of human metastatic melanoma cells through an authentic dermal-epidermal junction is associated with dissolution of native collagen types IV and VII.
Melanoma research 2000;10(5):427-34.
2000: Alistair Cochran
The pathologist's role in sentinel lymph node evaluation.
Seminars in nuclear medicine 2000;30(1):11-7.
1999: Alistair Cochran
Surgical pathology remains pivotal in the evaluation of 'sentinel' lymph nodes.
The American journal of surgical pathology 1999;23(10):1169-72.
1998: L Thomas; Alistair Cochran
[Managing cutaneous melanoma].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 1998;2(6):732-46.
1998: Raymond L Barnhill; Michael Piepkorn; Alistair Cochran; E Flynn; T Karaoli; J Folkman
Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases.
Archives of dermatology 1998;134(8):991-4.
1997: Jean-François Doré; P Maisonneuve; Maria Sofia Cattaruzza; Philippe Autier; Alistair Cochran; P Boyle
A molecular epidemiological approach to the study of expression of a metastasis marker in primary melanomas and its correlation with individual patient's risk of recurrence or metastasis.
Melanoma research 1997;7 Suppl 2():S121-5.
1995: Klaus J Busam; Marianne Berwick; K Blessing; K Fandrey; S Kang; T Karaoli; J Fine; Alistair Cochran; W L White; J Rivers
Tumor vascularity is not a prognostic factor for malignant melanoma of the skin.
The American journal of pathology 1995;147(4):1049-56.
1994: R L Barnhill; Klaus J Busam; Marianne Berwick; K Blessing; Alistair Cochran; D E Elder; K Fandrey; T Karaoli; W L White
Tumour vascularity is not a prognostic factor for cutaneous melanoma.
Lancet 1994;344(8931):1237-8.
1994: Alistair Cochran
The role of the histopathologist in the diagnosis of dysplastic naevi.
Histopathology 1994;24(6):589-90.
1994: D A Litman; Alistair Cochran; S L Hirshowitz
False-positive HMB-45 staining of axillary apocrine cells.
Acta cytologica 1994;38(3):489-91.
1994: Leslie A Wanek; Robert Elashoff; T M Goradia; D L Morton; Alistair Cochran
Application of multistage Markov modeling to malignant melanoma progression.
Cancer 1994;73(2):336-43.
1993: A Longin; N Berger-Dutrieux; B Fontaniere; Alistair Cochran; M Devonec; D Dolbeau; M Guillaud; J C Laurent
Studies of monoclonal antibody BL2-10D1 as a marker for the detection of the urothelial origin of tumors.
Cancer 1993;72(9):2651-5.
1993: D L Morton; D G Davtyan; Leslie A Wanek; Leland J Foshag; Alistair Cochran
Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness.
Cancer 1993;71(11):3737-43.
1993: S W Binder; C Asnong; E Paul; Alistair Cochran
The histology and differential diagnosis of Spitz nevus.
Seminars in diagnostic pathology 1993;10(1):36-46.
1993: Alistair Cochran; S Binder; F Remotti
The role of microscopic evaluation in the management of cutaneous melanoma.
Cancer treatment and research 1993;65():69-102.
1992: D L Morton; Duan-Ren Wen; J H Wong; J S Economou; L A Cagle; F K Storm; Leland J Foshag; Alistair Cochran
Technical details of intraoperative lymphatic mapping for early stage melanoma.
Archives of surgery (Chicago, Ill. : 1960) 1992;127(4):392-9.
1991: Z L Chen; Duan-Ren Wen; W F Coulson; A E Giuliano; Alistair Cochran
Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology.
Disease markers 1991;9(5):239-48.
1991: C Clemente; Alistair Cochran; D E Elder; A Levene; R M MacKie; M C Mihm; F Rilke; N Cascinelli; T B Fitzpatrick; A J Sober
Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme.
Human pathology 1991;22(4):313-9.
1991: Alistair Cochran
Micrometastases in melanoma.
The Western journal of medicine 1991;154(1):95-6.
1990: A S Fink; C A Kosakowski; J R Hiatt; Alistair Cochran
Periappendicitis is a significant clinical finding.
American journal of surgery 1990;159(6):564-8.
1989: K E Kliewer; Alistair Cochran
A review of the histology, ultrastructure, immunohistology, and molecular biology of extra-adrenal paragangliomas.
Archives of pathology & laboratory medicine 1989;113(11):1209-18.
1989: EE Sterns; Alistair Cochran
Monoclonal antibodies in the diagnosis and treatment of carcinoma of the breast.
Surgery, gynecology & obstetrics 1989;169(1):81-98.
1989: D S Hoon; T Jung; J Naungayan; Alistair Cochran; D L Morton; william mcbride
Modulation of human macrophage functions by gangliosides.
Immunology letters 1989;20(4):269-75.
1989: K E Kliewer; D R Wen; P A Cancilla; Alistair Cochran
Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques.
Human pathology 1989;20(1):29-39.
1988: Alistair Cochran; Gary N Holland; Romaine E Saxton; B E Damato; W R Foulds; harvey Herschman; R Y Foos; B R Straatsma; W R Lee
Detection and quantification of S-100 protein in ocular tissues and fluids from patients with intraocular melanoma.
The British journal of ophthalmology 1988;72(11):874-9.
1988: E Paul; Alistair Cochran
Immunostaining of tissue sections previously stained with hematoxylin and eosin.
Disease markers 1988;6(4):231-6.
1988: Romaine E Saxton; M W Burke; B Torbett; M Fairhurst; D L Morton; Alistair Cochran
Detection of malignant melanoma with monoclonal antibodies.
Disease markers 1988;6(2):97-108.
1988: S A Jitawi; Alistair Cochran; P A Cancilla; D R Wen
The expression of S-100 protein and neuron-specific enolase in meningiomas.
Disease markers 1988;6(2):109-17.
1988: E Paul; Alistair Cochran; D R Wen
Immunohistochemical demonstration of S-100 protein and melanoma-associated antigens in melanocytic nevi.
Journal of cutaneous pathology 1988;15(3):161-5.
1988: D S Hoon; R F Irie; Alistair Cochran
Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2.
Cellular immunology 1988;111(2):410-9.
1988: C M Haskell; Alistair Cochran; S H Barsky; R J Steckel
Metastasis of unknown origin.
Current problems in cancer 1988;12(1):5-58.
1988: Alistair Cochran
Melanoma markers: biological and diagnostic considerations.
Monographs in pathology 1988;(30):35-49.
1987: B J Glasgow; D R Wen; S Al-Jitawi; Alistair Cochran
Antibody to S-100 protein aids the separation of pagetoid melanoma from mammary and extramammary Paget's disease.
Journal of cutaneous pathology 1987;14(4):223-6.
1987: D S Hoon; E L Korn; Alistair Cochran
Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans.
Cancer research 1987;47(6):1740-4.
1987: D S Hoon; R J Bowker; Alistair Cochran
Suppressor cell activity in melanoma-draining lymph nodes.
Cancer research 1987;47(6):1529-33.
1987: E Paul; D R Wen; Alistair Cochran
Variations in S-100 protein expression in naevocellular naevi may be related to metabolic activity.
The British journal of dermatology 1987;116(3):371-8.
1987: M Hachida; P Naruns; S Morris; I Irie; Alistair Cochran; D L Morton
Bronchial anastomosis with a tissue adhesive.
The Journal of thoracic and cardiovascular surgery 1987;93(3):344-9.
1987: M S Nestor; Alistair Cochran; A R Ahmed
Mononuclear cell infiltrates in bullous disease.
The Journal of investigative dermatology 1987;88(2):172-5.
1986: P A Cancilla; Alistair Cochran; F Naeim; J W Said
Diagnostic immunopathology.
The Western journal of medicine 1986;145(1):65-73.
1986: S Bhuta; J M Mirra; Alistair Cochran
Myxoid malignant melanoma. A previously undescribed histologic pattern noted in metastatic lesions and a report of four cases.
The American journal of surgical pathology 1986;10(3):203-11.
1986: G Jundt; A Schulz; E Paul; Alistair Cochran; harvey Herschman
S-100 protein in amelanotic melanoma. A convenient immunocytochemical approach compared to electron microscopy.
Pathology, research and practice 1986;181(1):37-44.
1986: P L Naruns; J A Nizze; Alistair Cochran; M B Lee; D L Morton
Recurrence potential of thin primary melanomas.
Cancer 1986;57(3):545-8.
1986: V J McGovern; Alistair Cochran; E P Van der Esch; J H Little; R MacLennan
The classification of malignant melanoma, its histological reporting and registration: a revision of the 1972 Sydney classification.
Pathology 1986;18(1):12-21.
1985: Alistair Cochran; D R Wen
S-100 protein as a marker for melanocytic and other tumours.
Pathology 1985;17(2):340-5.
1985: Jay Pepose; G N Holland; M S Nestor; Alistair Cochran; R Y Foos
Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease.
Ophthalmology 1985;92(4):472-84.
1985: Alistair Cochran; W S Foulds; B E Damato; G E Trope; L Morrison; W R Lee
Assessment of immunological techniques in the diagnosis and prognosis of ocular malignant melanoma.
The British journal of ophthalmology 1985;69(3):171-6.
1984: Alistair Cochran; D R Wen; harvey Herschman
Occult melanoma in lymph nodes detected by antiserum to S-100 protein.
International journal of cancer. Journal international du cancer 1984;34(2):159-63.
1984: L D Wells; C A Bertelsen; E A Clairborne; Alistair Cochran
Spitz's nevus in a "black" child of mixed ancestry.
The American Journal of dermatopathology 1984;6 Suppl():271-6.
1984: M Katano; Romaine E Saxton; Alistair Cochran; R F Irie
Establishment of an ascitic human melanoma cell line that metastasizes to lung and liver in nude mice.
Journal of cancer research and clinical oncology 1984;108(2):197-203.
1983: E Abemayor; Alistair Cochran; T C Calcaterra
Metastatic cancer to the larynx. Diagnosis and management.
Cancer 1983;52(10):1944-8.
1983: A Grönberg; Alistair Cochran; K Kärre; G Klein; Gunnar Klein; R Kiessling
Incidence and type of tumors induced by DMBA carcinogenesis in H-2 congenic strains on a B10 background.
International journal of cancer. Journal international du cancer 1983;32(2):247-52.
1983: Alistair Cochran; G N Holland; D R Wen; harvey Herschman; W R Lee; R Y Foos; B R Straatsma
Detection of cytoplasmic S-100 protein in primary and metastatic intraocular melanomas.
Investigative ophthalmology & visual science 1983;24(8):1153-5.
1983: Alistair Cochran; M S Nestor; J E Groopman; A R Ahmed
Tumor infiltrates in acquired immunodeficiency syndrome patients with Kaposi's sarcoma.
Lancet 1983;1(8321):416.
1983: D H Kern; C A Bertelsen; B D Mann; M A Campbell; D L Morton; Alistair Cochran
Clinical application of the clonogenic assay.
Annals of clinical and laboratory science 1983;13(1):10-5.
1983: D R Wen; S Bhuta; harvey Herschman; R B Gaynor; Alistair Cochran
S-100 protein: a marker for melanocytic tumors.
Annals of the New York Academy of Sciences 1983;420():261-6.
1983: Jay Pepose; M S Nestor; G N Holland; Alistair Cochran; R Y Foos
An analysis of retinal cotton-wool spots and cytomegalovirus retinitis in the acquired immunodeficiency syndrome.
American journal of ophthalmology 1983;95(1):118-20.
1982: D H Kern; M A Campbell; Alistair Cochran; M W Burk; D L Morton
Cloning of human solid tumors in soft agar.
International journal of cancer. Journal international du cancer 1982;30(6):725-9.
1982: A E Giuliano; Alistair Cochran; D L Morton
Melanoma from unknown primary site and amelanotic melanoma.
Seminars in oncology 1982;9(4):442-7.
1982: Alistair Cochran; D R Wen; harvey Herschman; R B Gaynor
Detection of S-100 protein as an aid to the identification of melanocytic tumors.
International journal of cancer. Journal international du cancer 1982;30(3):295-7.
1982: Eric Culbert; Alistair Cochran; G B Clements
Lymphoid cell lines as indicators of lymphokine generation.
Scandinavian journal of immunology 1982;16(2):163-9.
1982: C Callery; Alistair Cochran; D J Roe; W Rees; S David Nathanson; J K Benedetti; R M Elashoff; D L Morton
Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes.
Annals of surgery 1982;196(1):69-75.
1982: L J Morrison; Alistair Cochran; A A Gibson; M L Willoughby; I A More
Establishment and characterization of human neuroblastoma and ganglioneuroblastoma cell lines.
British journal of cancer 1982;45(4):531-42.
1982: L J Morrison; Alistair Cochran; G M Baird; A M Campbell; M L Willoughby
Tumor-directed immunity in human neuroblastoma.
The American journal of pediatric hematology/oncology 1982;4(1):3-9.
1981: S Argov; Alistair Cochran; K Kärre; Gunnar Klein; G Klein
Incidence and type of tumors induced in C57BL bg/bg mice and +/bg littermates by oral administration of DMBA.
International journal of cancer. Journal international du cancer 1981;28(6):739-46.
1981: Alistair Cochran; Marc Buyse; F J Lejeune; E Macher; J Revuz; P Rümke
Adjuvant reactivity predicts survival in patients with "high-risk" primary malignant melanoma treated with systemic BCG. EORTC Malignant Melanoma Cooperative Group Writing Committee.
International journal of cancer. Journal international du cancer 1981;28(5):543-50.
1981: S J Finck; Alistair Cochran; C R Vitek; D L Morton
Localized hirsutism after radical inguinal lymphadenectomy.
The New England journal of medicine 1981;305(16):958.
1981: L J Morrison; Alistair Cochran; G M Baird; A M Campbell; M L Willoughby
Tumor-directed immunity in neuroblastoma patients and their related and unrelated contacts.
The American journal of pediatric hematology/oncology 1981;3(4):353-61.
1981: Jan Bubeník; Alistair Cochran; G Todd; M Malkovský; Tána Jandlová; E Suhajová; M Boubelík
A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells.
Neoplasma 1981;28(2):185-93.
1980: G Todd; C W Chan; Alistair Cochran; R Kennedy; R M Mackie; L J Morrison
In vitro reaction of cancer patients and others to Bacillus Calmette-Gueérin.
International journal of cancer. Journal international du cancer 1980;26(3):285-8.
1980: N Kuzumaki; I A More; Alistair Cochran; G Klein
Thirteen new mammary tumor cell lines from different mouse strains.
European journal of cancer 1980;16(9):1181-92.
1979: N Kuzumaki; R Ber; I A More; Alistair Cochran; F Weiner; G Klein
Viral expression and immunogenicity of CBA mammary carcinomas and their hybrid lines with an L-cell derivative (A9HT).
European journal of cancer 1979;15(10):1253-61.
1979: Alistair Cochran; R McLean
Accidental injection of Freund's adjuvant without systemic sequelae.
Lancet 1979;2(8138):356.
1979: L J Morrison; Alistair Cochran; R M Mackie; C E Ross; G Todd; C Garland; G Garland
Indirect leukocyte migration assay in patients with malignant melanoma.
International journal of cancer. Journal international du cancer 1979;24(1):11-6.
1979: C E Ross; Alistair Cochran; A M Jackson; R M Mackie; L J Ogg
The mechanism of tumour cell induced inhibition of human leucocyte migration.
European journal of cancer 1979;15(7):995-1000.
1978: A M Jackson; B M Vose; Alistair Cochran
Tumour-associated antigens in cystic melanomas.
European journal of cancer 1978;14(5):543-7.
1978: J A Hunter; S Zaynoun; W D Paterson; S S Bleehen; R Mackie; Alistair Cochran
Cellular fine structure in the invasive nodules of different histogenetic types of malignant melanoma.
The British journal of dermatology 1978;98(3):255-72.
1977: Alistair Cochran
Immunologic mechanisms in malignant melanoma of the skin.
Transactions of the ophthalmological societies of the United Kingdom 1977;97(3):385-8.
1977: Alistair Cochran; R M Mackie; A M Jackson; L J Ogg; C E Ross
Immunological changes in cancer patients receiving BCG.
Developments in biological standardization 1977;38():441-8.
1977: C G McGregor; Alistair Cochran; L J Ogg; G R Gray; I S Smith; G Gillespie; J Forrester
Immunological and other laboratory studies of patients receiving short-term cimetidine therapy.
Lancet 1977;1(8003):122-3.
1976: Alistair Cochran; R M Mackie; C E Ross; L J Ogg; A M Jackson
Leukocyte migration inhibition by cancer patients' sera.
International journal of cancer. Journal international du cancer 1976;18(3):274-81.